Diverse Biotech is focused on improving health and wellness. Our mission is transform breakthrough discoveries into innovative therapeutics that address today’s most pressing medical needs and improve the quality of life of our patients and loved ones.
We aim to create a healthy, happy, and sustainable world for our patients, colleagues, investors, and communities through the advanced technological research and novel discoveries to which our team is committed.
The single driving force behind what we do is to extend or save lives. That’s our biggest goal.
Clinical Trials: Diverse Biotech is an innovative, clinical-stage biopharmaceutical research company that is committed to discovering and developing novel therapeutics from its proprietary cannabinoid product platform. Our formulas are novel discoveries for improving health and well-being of cancer patients around the world. Operating through the FDA New Drug Application process, we continue to focus our research on conditions that represent some of today’s most significant health challenges like cancer and neurological disease. At Diverse Biotech, we’re combining our experience, scientific research and business acumen to do more of what we’re passionate about: improving health and improving lives.
Cancer DNA sequencing: Each person’s cancer has a unique combination of genetic changes, and tumor DNA sequencing is a test to identify these unique DNA changes. In some cases, knowledge of the genetic alterations in a cancer can help determine a treatment plan. Our DNA Cancer Screening division has multiple oncology practices across the country where samples are collected and tested for DNA mutations that give insight to oncologist for heading off cancer before it becomes life threatening to their patients.
Countless lives of everyday people around the world are devastated by a cancer diagnosis, each day. We want to make a difference and develop novel treatments that save lives and give people hope.